The Oncology Institute, Inc.TOIIWNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank17
3Y CAGR-54.6%
5Y CAGR-42.8%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-54.6%/yr
Annual compound
5Y CAGR
-42.8%/yr
Recent deceleration
Percentile
P17
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
5 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 0.25 | -66.3% |
| 2023 | 0.73 | -14.0% |
| 2022 | 0.85 | -67.6% |
| 2021 | 2.62 | -23.8% |
| 2020 | 3.44 | -14.2% |
| 2019 | 4.01 | - |
| 2018 | 0.00 | - |